This study is conducted to check how well the Dermapen 4™ microneedling device works with MG-CLR serum for treating acne over 12 weeks.
Female subjects aged between 18-45 years (both ages inclusive)
Fitzpatrick skin phototype I to VI.
Subjects having IGA score of 2 and 3.
Subjects who have not received any kind of treatment for acne 1 month before the start of the study.
Subjects with known skin condition that may impact the assessment.
Subjects with active Herpes labialis infection.
Subjects known to have bleeding and clotting disorders (self-declared).
Subjects known to have connective tissue disorders.